{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:32:08Z","timestamp":1761093128885,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005977","name":"Kaiser Permanente","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.urolonc.2021.03.023","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T07:48:04Z","timestamp":1620114484000},"page":"783.e11-783.e19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prospective validation of the Kaiser Permanente prostate cancer risk calculator in a contemporary, racially diverse, referral population"],"prefix":"10.1016","volume":"39","author":[{"given":"Joseph C.","family":"Presti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Alexeeff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Horton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Prausnitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Avins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.urolonc.2021.03.023_bib0001","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2018.3710","article-title":"Screening for prostate cancer: US Preventive Services Task Force recommendation statement","volume":"319","author":"Grossman","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2021.03.023_bib0002","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/JU.0000000000000617","article-title":"Update of the standard operating procedure on the use of multiparametric magnetic resonance imaging for the diagnosis, staging and management of prostate cancer","volume":"203","author":"Bjurlin","year":"2020","journal-title":"J Urol"},{"year":"2020","series-title":"Prostate Cancer Early Detection","key":"10.1016\/j.urolonc.2021.03.023_bib0003"},{"key":"10.1016\/j.urolonc.2021.03.023_bib0004","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnci\/djj131","article-title":"Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial","volume":"98","author":"Thompson","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2021.03.023_bib0005","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.juro.2010.09.101","article-title":"The prostate cancer risk calculator from the prostate cancer prevention Trial underestimates the risk of high grade cancer in contemporary referral patients","volume":"185","author":"Ngo","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2021.03.023_bib0006","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"Ca Cancer J Clin"},{"key":"10.1016\/j.urolonc.2021.03.023_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2020.05.011","article-title":"Prospective development of a prostate cancer risk calculator in a racially diverse population: the kaiser permanente prostate cancer risk calculator","volume":"38","author":"Presti","year":"2020","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.03.023_bib0008","doi-asserted-by":"crossref","first-page":"55","DOI":"10.7326\/M14-0697","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urolonc.2021.03.023_bib0009","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1078-1439(03)00031-0","article-title":"The utility of apical anterior horn biopsies in prostate cancer detection","volume":"21","author":"Meng","year":"2003","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2021.03.023_bib0010","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/01.ju.0000132134.10470.75","article-title":"Prostate cancer detection with office based saturation biopsy in a repeat biopsy population","volume":"172","author":"Rabets","year":"2004","journal-title":"J Urol"},{"issue":"10","key":"10.1016\/j.urolonc.2021.03.023_bib0011","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jama.2015.11082","article-title":"Evaluating discrimination of risk prediction models: The C statistic","volume":"314","author":"Pencina","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.urolonc.2021.03.023_bib0012","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"Delong","year":"1988","journal-title":"Biometrics"},{"issue":"9","key":"10.1016\/j.urolonc.2021.03.023_bib0013","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O","article-title":"A comparison of goodness-of-fit tests for the logistic regression model","volume":"16","author":"Hosmer","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.urolonc.2021.03.023_bib0014","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.urology.2014.02.035","article-title":"Prostate cancer prevention trial risk calculator 2.0 for the prediction of low- vs. high-grade prostate cancer","volume":"83","author":"Ankerst","year":"2014","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2021.03.023_bib0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.eururo.2018.05.003","article-title":"A contemporary prostate biopsy risk calculator based on multiple heterogeneous cohorts","volume":"74","author":"Ankerst","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2021.03.023_bib0016","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJMms1914228","article-title":"Reconsidering prostate cancer mortality \u2013 the future of PSA screening","volume":"382","author":"Welch","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2021.03.023_bib0017","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1056\/NEJMoa031918","article-title":"Prevalence of prostate cancer among men with a Prostate-Specific Antigen level <4.0 ng per milliliter","volume":"350","author":"Thompson","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2021.03.023_bib0018","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.2017.12126","article-title":"Discrimination and calibration of clinical prediction models. Users\u2019 guides to the medical literature","volume":"318","author":"Alba","year":"2017","journal-title":"JAMA"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921001332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143921001332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:23:10Z","timestamp":1761042190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143921001332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":18,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1078143921001332"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.03.023","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective validation of the Kaiser Permanente prostate cancer risk calculator in a contemporary, racially diverse, referral population","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2021.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}